Cancer diagnostic tool to be showcased at Arab Health

Zilico's Chief Executive, Mr Sameer Kothari, will present the system at the four-day exhibition, which takes place at the Dubai International Convention & Exhibition Centre from 28-31 January. Zilico Ltd will be located at Hall 7 stand 7B67.

ZedScan I, the first application of the device, is positioned within the referral population, will reduce the number of biopsies taken and has the potential to facilitate the wider use of 'see and treat' modality.

The system consists of a portable hand-held device, a single-use disposable sleeve and docking station and is safe and painless.

Using electrical impedance spectroscopy technology, it can measure the resistivity of cells and so detect changes as cells progress from normal to precancerous and then to cancerous.

The referral application completed a pivotal European trial of 400 women in 2011 across three hospitals in the UK and Ireland.

The company has since been disseminating these results at key scientific meetings across the world, including recently being awarded the 'Best Scientific Presentation' at the ASCCP 2012, and attendance at several of the world's most high-profile healthcare exhibitions, such as Medica and AdvaMed.

As the biggest healthcare exhibition and medical congress in the Middle East, attracting more than 80,000 visitors over the four days, Mr Kothari is hoping to discuss potential commercial partnerships with sales and marketing companies who are experienced in selling into gynaecology.

Mr Kothari said: "ZedScan I has the potential to make a significant impact on how women are managed within the cervical cancer pathway.

"This potential has clearly been recognised as we've received significant from across the globe over the last few months. We're now looking forward to meeting interested parties at Arab Health."

Arab Health will take place between the 28-31 January 2013 at the Dubai International Convention & Exhibition Centre. Zilico Ltd will be located at Hall 7 Stand 7B67.